Medical Oncology and Hematology Group PC-Guilford — Guilford, Connecticut

Medical Oncology and Hematology Group PC-Guilford is a clinical research site located in Guilford, Connecticut, United States 06437.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Medical Oncology and Hematology Group PC-Guilford has participated in 11 clinical trials.

Therapeutic areas: Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, FGFR1 Gene Amplification.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Guilford

Browse all research sites in Connecticut · View every site in Guilford

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical Oncology and Hematology Group PC-Guilford?

Medical Oncology and Hematology Group PC-Guilford has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical Oncology and Hematology Group PC-Guilford conducted?

Medical Oncology and Hematology Group PC-Guilford has 11 clinical trials on record. Their work covers Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, FGFR1 Gene Amplification.

Is Medical Oncology and Hematology Group PC-Guilford accredited by Crixeo Clinical Trials?

Medical Oncology and Hematology Group PC-Guilford has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical Oncology and Hematology Group PC-Guilford?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.